跳至主要内容
临床试验/NCT03889470
NCT03889470Unknown4 期

A Randomized Comparison of Nitroglycerin Versus Placebo as Spasmolytic Regimen to Prevent Moderate to Severe Radial Artery Spasm in Radial Center

Hermina Heart Center Kemayoran1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年3月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
1,000
试验地点
1
主要终点
The incidence of Moderate to severe radial artery spasm

研究概览

简要总结

The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.

详细描述

Patients will be randomized to receive either 200 microgram NTG or placebo (saline) at the beginning of the procedure soon after radial sheath placement. The operators will be blinded to both assignment. The primary outcome is the incidence of moderate to severe RAS evaluated by the operators during the radial procedure.

Both NTG and placebo will be administered using an identical syringe to keep the operators blinded to the treatment allocation. Radial angiogram is mandatory to measure the diameter of both radial and ulnar arteries. Doppler ultrasound of the radial artery will be examined at the day after the procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients undergoing transradial catheterisation using proximal radial artery puncture technique

排除标准

  • Blood pressure <100 mmHg
  • Refuse to participate

研究组 & 干预措施

200 microgram NTG

Active Comparator

200 microgram NTG through the radial sheath

干预措施: NTG 1 MG/ML Injectable Solution (Drug)

Saline

Placebo Comparator

Saline infusion through the radial sheath

干预措施: NTG 1 MG/ML Injectable Solution (Drug)

结局指标

主要结局

The incidence of Moderate to severe radial artery spasm

时间窗: During the index procedure

arm pain associated with catheter manipulation (RAS grade 2 to 4)

次要结局

未报告次要终点

研究者

发起方
Hermina Heart Center Kemayoran
申办方类型
Other
责任方
Principal Investigator
主要研究者

Surya Dharma, MD, PhD

MD, PhD

Hermina Heart Center Kemayoran

研究点 (1)

Loading locations...

相似试验

Nitroglycerin as Spasmolytic Regimen for RAS... | 临床试验